CRVRX Performance — NYLI CBRE Real Estate Fund, Investor Class
Data updated: 2026-09-23
CRVRX returned +17.60% year to date and +18.27% over one year to Jul 2026. Annualised returns are +8.19% over 3 years and +2.25% over 5 years. Against its Real Estate category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $127, against $132 for the category, and to $118 over one year, against $118. Volatility over the past three years was 17.11% a year. In the 12 months to Jul 2026 the fund lost a net $35.5M, and assets reached $221.92M.
CRVRX Growth of $100
What $100 invested in NYLI CBRE Real Estate Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Real Estate category average over the same months.
| Period | CRVRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $118 | $118 |
| 3 years (Aug 2023 – Jul 2026) | $127 | $132 |
| 5 years (Aug 2021 – Jul 2026) | $112 | $117 |
| Since data start (Feb 2020 – Jul 2026) | $114 | $144 |
CRVRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.60% |
| 1 year | +18.27% |
| 3 years (annualised) | +8.19% |
| 5 years (annualised) | +2.25% |
CRVRX Annual Returns
Calendar-year total returns of NYLI CBRE Real Estate Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +17.60% |
| 2025 | −0.65% |
| 2024 | +1.41% |
| 2023 | +11.78% |
| 2022 | −27.23% |
| 2021 | +52.02% |
| 2020 (Feb–Dec) | −22.00% |
CRVRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.7% | +8.5% | −6.0% | +9.4% | −0.4% | +1.5% | +1.7% | — | — | — | — | — |
| 2025 | +0.2% | +4.2% | −2.7% | −1.9% | +1.0% | −0.5% | −1.2% | +2.8% | −0.2% | −1.4% | +2.4% | −2.9% |
| 2024 | −4.5% | +1.7% | +1.6% | −8.3% | +4.9% | +1.3% | +7.0% | +5.4% | +2.5% | −4.2% | +3.0% | −7.4% |
| 2023 | +10.8% | −5.3% | −2.1% | +0.1% | −3.9% | +4.4% | +1.3% | −3.7% | −7.4% | −2.9% | +12.3% | +9.8% |
| 2022 | −8.4% | −4.7% | +6.5% | −3.1% | −5.5% | −7.6% | +8.9% | −5.9% | −12.4% | +2.9% | +5.7% | −5.2% |
| 2021 | +2.0% | +3.2% | +5.4% | +9.1% | +0.8% | +2.8% | +4.4% | +2.8% | −3.8% | +8.3% | −1.3% | +9.7% |
| 2020 | — | −12.7% | −25.8% | +2.4% | +1.3% | +3.1% | +4.2% | 0.0% | −3.4% | −2.9% | +10.7% | +4.0% |
CRVRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 17.11%
- 3-year Sharpe ratio: 0.22 (vs 4.5% risk-free rate)
- Best month: +12.33% (Nov 2023)
- Worst month: −8.28% (Apr 2024)
CRVRX Fund Flows
Monthly money in and out of NYLI CBRE Real Estate Fund, from SEC Form N-PORT.
- 12-month net flow: −$35.5M
- 12-month gross sales (incl. reinvestments): $26.9M
- Sales ÷ redemptions: 0.43×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $2.0M | $4.2M | −$2.2M |
| Jun 2026 | $1.4M | $5.0M | −$3.6M |
| May 2026 | $1.0M | $3.4M | −$2.4M |
| Apr 2026 | $3.7M | $5.0M | −$1.4M |
| Mar 2026 | $2.2M | $7.6M | −$5.4M |
| Feb 2026 | $2.1M | $5.2M | −$3.1M |
| Jan 2026 | $1.9M | $6.7M | −$4.7M |
| Dec 2025 | $3.4M | $7.7M | −$4.3M |
| Nov 2025 | $1.0M | $4.2M | −$3.2M |
| Oct 2025 | $3.8M | $4.5M | −$726K |
| Sep 2025 | $2.0M | $5.1M | −$3.1M |
| Aug 2025 | $2.4M | $3.8M | −$1.4M |
CRVRX Assets Under Management
Net assets of NYLI CBRE Real Estate Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $221.92M |
| 2026-04-30 | $224.65M |
| 2026-01-31 | $212.23M |
| 2025-10-31 | $221.54M |
| 2025-07-31 | $225.39M |
| 2025-04-30 | $235.95M |
| 2025-01-31 | $268.83M |
| 2024-10-31 | $294.35M |
| 2024-07-31 | $289.71M |
| 2024-04-30 | $263.98M |
| 2024-01-31 | $277.71M |
| 2023-10-31 | $253.35M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.